ZEB2 and glioblastoma: In an article by Pang et al., it was found that miR-590-3p inhibits cancer cell migration, invasion, and epithelial–mesenchymal transition (EMT) in glioblastoma multiform through targeting ZEB1 and ZEB2 [38].